World Library  
Flag as Inappropriate
Email this Article

Serotonin releasing agent

Article Id: WHEBN0023058155
Reproduction Date:

Title: Serotonin releasing agent  
Author: World Heritage Encyclopedia
Language: English
Subject: Citalopram, MDAT, Amiflamine, Indeloxazine, Para-Chlorophenylpiperazine
Publisher: World Heritage Encyclopedia

Serotonin releasing agent

A serotonin releasing agent (SRA) is a type of drug which induces the release of serotonin and thus elevates the levels of serotonin in the body and/or brain.

Examples and use

MDMA, MDEA, MDA, and MBDB, among other relatives (see MDxx), are recreational drugs termed entactogens. They act as releasing agents of not only serotonin, but of dopamine and norepinephrine as well, and also agonize serotonin receptors such as 5-HT2A.

Fenfluramine, chlorphentermine, and aminorex were used as appetite suppressants but they were discontinued due to concerns of cardiac valvulopathy. This side effect has been attributed not only to their action as SRAs but due to potent agonism of the 5-HT2B receptor as well. The designer drugs MDMA and 4-methylaminorex which are also SRAs and 5-HT2B agonists have been reported to cause this effect as well.

Many tryptamines, such as DMT, DET, DPT, DiPT, psilocin, and bufotenin are SRAs as well as non-selective serotonin receptor agonists.[1] These drugs are serotonergic psychedelics, which is a consequence of their ability to activate the 5-HT2A receptor.

αET and αMT, also tryptamines, are serotonin, norepinephrine, and dopamine releasing agents and non-selective serotonin receptor agonists which were formerly used as antidepressants.[1] They have since been discontinued and are now encountered solely as recreational drugs.

Tramadol, in addition to its opioid and norepinephrine reuptake-inhibiting effects, is an SRA and is used as an analgesic. Indeloxazine is an SRA and norepinephrine reuptake inhibitor used as a nootropic and neuroprotective.

See also


  1. ^ a b Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB (October 2014). "Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes". Psychopharmacology 231 (21): 4135–44.  

Further reading

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.